Zdravlje receives an EU Wholesale Distribution Authorization by BDA

18/08/2022
zdravlje-news-logo.jpg

We are pleased to announce that as of 16 August Zdravlje Pharmaceuticals (Bulgaria), a subsidiary of Zdravlje Leskovac, has received a Wholesale Distribution Authorization by the Bulgarian Drug Agency (BDA).

“This is an important step for both our Commercial and Contract Development and Manufacturing (CDMO) business lines as we are able to offer end-to-end solutions for our customers, including the import, test and release of goods in the EU, said Kiren Naidoo, CEO of Zdravlje.


How we can help?

Reach out to us and let’s discuss how we can support your pharmaceutical manufacturing needs.


CONTACT US


Zdravlje Company Data | Terms Of Use | Privacy policy | Personal Data Processing

© 2025 Zdravlje AD Leskovac. All rights reserved.